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Trimethylammonium diphenylhexatrieneNormal human lymphocytes resisted the hydrolytic action of secretory phospholipase A2 but became susceptible
to the enzyme following treatmentwith a calcium ionophore, ionomycin. To test the hypothesis that this suscep-
tibility requires exposure of the anionic lipid phosphatidylserine on the external face of the cell membrane,
experimentswere repeatedwith a humanBurkitt's lymphomacell line (Raji cells). In contrast to normal lympho-
cytes or S49mouse lymphoma cells,most of the Raji cells (83%) did not translocate phosphatidylserine to the cell
surface upon treatment with ionomycin. Those few that did display exposed phosphatidylserine were hydro-
lyzed immediately upon addition of phospholipase A2. Interestingly, the remaining cells were also completely
susceptible to the enzyme but were hydrolyzed at a slower rate and after a latency of about 100 s. In contradis-
tinction to the defect in phosphatidylserine translocation, Raji cells did display other physicalmembrane changes
upon ionomycin treatment thatmay be relevant to hydrolysis by phospholipase A2. These changeswere detected
by merocyanine 540 and trimethylammonium diphenylhexatriene ﬂuorescence and were common among
normal lymphocytes, S49 cells, and Raji cells. The levels of these latter effects correspondedwell with the relative
rates of hydrolysis among the three cell lines. These results suggested that while phosphatidylserine enhances
the rate of cell membrane hydrolysis by secretory phospholipase A2, it is not an absolute requirement. Other
physical properties such as membrane order contribute to the level of membrane susceptibility to the enzyme
independent of phosphatidylserine.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Secretory phospholipase A2 (sPLA2) hydrolyzes phospholipids at the
sn-2 position producing free fatty acid and lysophospholipid. It repre-
sents a family of isozymes and is thought to participate in a broad
range of functions including generation of pro-inﬂammatorymediators,
protection against bacterial and fungal infections, digestion, participa-
tion in reproduction, nervous system development, andwound healing.
Furthermore, sPLA2 has been implicated in several pathologies such as
atherosclerosis, inﬂammatory diseases, septic shock, and cancer
(reviewed in [1]).
A major characteristic of sPLA2 is its extreme sensitivity to the bio-
physical properties of the bilayers onwhich it acts. This sensitivity is im-
portant because it prevents damage to the membranes of normal
healthy mammalian cells while allowing efﬁcient catalysis of bacterial
membranes and those of damaged or dying cells [2–6]. In particular,oung University, Provo, Utah
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l rights reserved.the membranes of several types of cultured leukocytes have been
reported to convert from being resistant to becoming susceptible to
the action of the enzyme during apoptosis and other forms of biochem-
ical cell death [4,5,7–10].
The nature of the biophysical changes in the cell membrane that
trigger catalysis by sPLA2 during cell death is not yet established. Nev-
ertheless, important clues have been identiﬁed from biophysical
studies of both artiﬁcial bilayers and living cells [6–8,10–18]. Two
prominent candidates have emerged: 1) a reduction in the strength
of interactions among adjacent phospholipids resulting in increased
lipid mobility and greater interlipid spacing and 2) the presence of
anionic lipids on the membrane surface [6,10,14,19]. The hypothesis
is that reduced interactions among neighboring phospholipids allow
substrates to migrate into the active site of adsorbed sPLA2, while
negative charge facilitates initial adsorption of the enzyme to the
membrane surface [11,18,20–22]. The primary source of these surface
anions during cell death is phosphatidylserine (PS). Ordinarily, this
lipid is conﬁned to the inner leaﬂet of the cell membrane, and several
enzymes are involved in maintaining that asymmetry [23]. However,
during apoptosis and other forms of cell death, PS is translocated to
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marker for processes that eliminate the dying cell such as phagocytosis
[24,26–28] and, perhaps, hydrolysis by sPLA2 [10,18,19]. Arguments for
the importance of lipid-neighbor interactions and of surface PS are
accumulating, although the existing evidence from cells depends on
temporal correlations rather than direct experimental manipulations
[6–8,10,14].
In order to distinguish more directly the potential roles of PS and
membrane lipid interactions in capacitating hydrolysis during cell
death, we have initiated a series of experiments with Raji Burkitt's
lymphoma cells. These cells are deﬁcient in their ability to express
the gene for scamblase, the enzyme primarily responsible for expo-
sure of PS during apoptosis [29–31]. Here, we report investigations
with a calcium ionophore, ionomycin, as the stimulator of cell
death. Ionomycin was chosen for our ﬁrst study because it stimulates
complete immediate exposure of PS and full hydrolytic susceptibility
to sPLA2 in other cultured lymphoma cells [7,9]. Since Raji cells orig-
inated from a human tumor, we used freshly-isolated normal human
lymphocytes as a control for comparison. Data were also compared to
that attained with a cell line used in previous studies, S49 mouse
lymphoma cells, as a positive control.
2. Materials and methods
2.1. Reagents
The monomeric aspartate-49 phospholipase A2 from the venom of
thewatermoccasin,Agkistrodon piscivorus piscivoruswas isolated accord-
ing to the procedure by Maraganore et al. [32]. Ionomycin, merocyanine
540 (MC540), propidium iodide, 1-(trimethylammoniumphenyl)- 6-
phenyl-1,3,5 hexatriene p-toluenesulfonate (TMA-DPH), and Alexa
Fluor 488 annexin V conjugate were acquired from Invitrogen (Carlsbad,
CA). The acrylodan-labeled fatty acid-binding protein (ADIFAB) was
purchased from FFA Sciences (San Diego, CA). Ionomycin and MC540
were dissolved as stock solutions in dimethylsulfoxide (DMSO), and
TMA-DPH was suspended in dimethylformamide. Annexin V, ADIFAB,
and propidium iodide were stored as aqueous solutions. Other reagents
(buffer, salts, detergent) were obtained from standard sources.
2.2. Preparation of cells
S49 mouse lymphoma cells were grown in DMEM at 37 °C in hu-
midiﬁed air containing 10% CO2.Raji human Burkitt's lymphoma cells
were grown at 37 °C at 5% CO2 in RPMI containing 10% fetal bovine
serum and L-glutamine. S49 and Raji cells were prepared as described
[5]. Normal human lymphocytes were isolated from residual whole
blood samples obtained during routine physical exams at the Brigham
Young University Student Health Center by density centrifugation
with Histopaque-1077 from Sigma-Aldrich (St. Louis, MO) according
to the manufacturer protocol. Purity of preparations was determined
by microscopic analysis of Wright-stained aliquots. On average, 91% of
the leukocytes in the samples were lymphocytes. Control experiments
revealed that standard procedures for eliminating contaminating eryth-
rocytes in lymphocyte preparations (≤12%) were not usable in these
experiments because they perturb cell membranes in ways that inter-
fere with the results. We therefore tested the impact of added erythro-
cytes on the experimental observations and determined that they did
not alter the results at concentrations below 50%. In ﬂow cytometry
experiments, erythrocytes and non-lymphocyte leukocytes were
excluded from the analyses.
For experiments, cells were washed and suspended in MBSS
(134 mM NaCl, 6.2 mM KCl, 1.6 mM CaCl2, 1.2 nM MgCl2, 18.0 mM
Hepes, 13.6 mM glucose, pH 7.4 at 37 °C) at a density of 0.4–3.0×106
cells/ml. Aliquots were transferred to quartz ﬂuorometer sample cells
and allowed 5 min to equilibrate in the relevant spectroﬂuorometer
(see below) for measurements of ﬂuorescence emission intensity andanisotropy or to polycarbonate tubes in a shaking water bath for ﬂow
cytometry. Sample homogeneity and temperature were maintained in
the spectroﬂuorometers by magnetic stirring and by circulating heated
water through a jacket in the sample chamber. All experiments and
incubationswere performed at 37 °C. In each procedurewhere ionomy-
cin was added to cell samples (600 nM ﬁnal), the experiment was
repeatedwith an equivalent volume of DMSO (0.5% v/v ﬁnal) to control
for the effects of the solvent.
2.3. Membrane hydrolysis
As a generic model for sPLA2, we used enzyme puriﬁed from snake
venom as described above. This source of enzymewas selected because
of its previous use in biophysical studies of cell death by calcium iono-
phore and because of its strong similarity to the human group X
sPLA2, the isoform that responds best to ionophore-stimulated cells
[10,16,17]. We veriﬁed these assertions for human lymphocytes using
samples of human groups IIa, V, and X sPLA2 generously provided by
Michael Gelb (University ofWashington) andWonhwa Cho (University
of Illinois, Chicago). In these calibration experiments, the group IIa
enzyme displayed 0.4% of the activity observed with snake venom
sPLA2 toward human lymphocytes treated with ionomycin whereas
the groups V and X isozymes exhibited 25.7% and 82.8% respectively.
These relative responses of the isozymes to ionomycin-treated lympho-
cytes were identical to those reported previously for S49 lymphoma
cells and therefore justiﬁed the use of the snake venom enzyme as an
assay for cell susceptibility to sPLA2 [10,16].
Fatty acid release from cell membranes was assayed in real time by
ﬂuorescence spectroscopy (Fluoromax 3, Horiba Jobin-Yvon, Edison, NJ
) using ADIFAB (excitation=390 nm, emission=432 and 505 nm,
bandpass=4 nm) [33]. After data acquisition was initiated, ADIFAB
(65 nM ﬁnal) was added and allowed adequate time to equilibrate.
The sample was then incubated with ionomycin for 10 min after
which sPLA2 (70 nM ﬁnal) was added. The generalized polarization
(GP) was calculated from the ﬂuorescence emission intensities at 505
and 432 nm (I505 and I432) in order to quantify the amount of fatty
acid produced [34].
GP ¼ I505−I432ð Þ
I505 þ I432ð Þ
ð1Þ
Propidium iodide ﬂuorescence (37 μM ﬁnal, excitation=537 nm,
emission=617 nm, bandpass=4 nm) was used to assess the propor-
tion of cells in the sample that were susceptible to hydrolysis by sPLA2
[8,9]. Addition and incubation times of reagents were as stated for ADI-
FAB assays with the exception that triton X-100 (0.25% ﬁnal v/v) was
added after the propidium iodide ﬂuorescence intensity became stable
(often>2000 s in human lymphocytes and Raji cells) to permeabilize
all cells and obtain a maximum signal. The proportions of cells in
relevant categories (PIA, “already dead”; PIB, “killed by ionomycin”; PIC,
“alive, but susceptible to sPLA2”) were quantiﬁed as follows (illustrated
in Fig. 1):
PIA ¼
Iss−I0ð Þ
Imax−I0ð Þ
ð2AÞ
PIB ¼
Iiono−Issð Þ
Imax−I0ð Þ
ð2BÞ
PIC ¼
IsPLA2−Iionoð Þ
Imax−I0ð Þ
ð2CÞ
where I0 is the average intensity during the ﬁrst 20 s after addition of
propidium iodide to the sample, Iss is the average intensity during the
50 s prior to addition of ionomycin, Iiono is the average intensity during
the 50 s prior to addition of sPLA2, IsPLA2 is the average intensity during
Fig. 1. Idealized diagram of propidium iodide ﬂuorescence time course during treatment
with ionomycin and sPLA2. See Eqs. (2A)–(2C) and associated text for explanation.
The dotted lines represent the times of addition of ionomycin (“+ iono”), sPLA2
(“+ sPLA2”), and triton X-100 (“+ triton”).
Fig. 2. Effect of ionomycin treatment on PS exposure. Panels A and B: Data represent the
level of staining by annexin V among cell subpopulations assayed by ﬂow cytometry.
Normal lymphocytes (A) were treated with DMSO (solid line) or ionomycin (dotted
line) and incubated with annexin V for 15 min and immediately transferred to the ﬂow
cytometer. Panel B: The percentages of normal lymphocytes (black), Raji cells (dark
gray), and S49 cells (light gray) staining positive for annexin V after addition of DMSO
or ionomycinwere identiﬁed from experiments such as those of panel A for 3–5 indepen-
dent samples. The white bar for “ionomycin” represents Raji cells treated with 1.2 μM
ionomycin instead of the typical 600 nM. The effects of cell type (22.2% of the variation)
and ionomycin (52.7% of the variation) were both signiﬁcant (pb0.0001) by two-way
analysis of variance. Interaction between cell type and drug treatmentwas also signiﬁcant,
indicating that the size of the effect of ionomycin depended on cell type (17.9% of the
variation, pb0.0001). One-way analysis of variance with a Bonferroni post-test on the
four groups treated with ionomycin revealed that the Raji cells with normal ionomycin
was the only distinguishable group (pb0.01).
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intensity after adding triton X-100.
2.4. Membrane biophysical properties
Data using MC540 (170 nM ﬁnal) was acquired at 585 nm
(excitation=540 nm, bandpass=4 nm) before the addition of the
probe (for background scattered and stray light), after a 5-min equili-
bration, 10 min after addition of ionomycin or DMSO, and duringhydro-
lysis by sPLA2. Data were analyzed by subtracting the background
intensity and calculating the change in emission intensities normalized
to the initial intensity (before ionomycin).
Steady-state ﬂuorescence anisotropy measurements (TMA-DPH)
were obtained with a PC-1 spectroﬂuorometer in the “L” conﬁguration
(ISS, Champaign, IL) using Glan-Thompson polarizers. Fluorescence
intensity was measured with excitation (350 nm, 16 nm bandpass)
and emission (452 nm, 16 nm bandpass) polarizers oriented at 0°
from vertical (parallel) and repeated with the excitation polarizer at
0° and the emission polarizer at 90° (perpendicular). The data were
adjusted for transmission efﬁciency of the emission monochromator
by calculating the ratio of emission intensity at 0° (v) and 90° (h) with
the excitation polarizer oriented at 90° (G):
G ¼ Ihv
Ihh
: ð3Þ
The TMA-DPH anisotropy was calculated using the traditional
equation:
r ¼ Ivv−GIvh
Ivv þ 2GIvh
ð4Þ
where Ivv and Ivh are the intensities with parallel and perpendicular
polarizer conﬁgurations, respectively.
2.5. Flow cytometry
The amount of PS exposed on the outer leaﬂet of the cell membrane
was determined by annexin V binding to the cells. Flow cytometry data
were collected using a FACSCanto ﬂow cytometer (BD Biosciences, San
Jose, CA) with an argon laser (488 nm) and an emission bandpass ﬁlter
that transmits 515–545 nm. Cells were treated with DMSO or ionomy-
cin (10–15 min) and concurrently labeled in MBSS with conjugated
annexin V at the dilution indicated by the manufacturer (Invitrogen).3. Results
3.1. Exposure of PS
Fig. 2A displays the effect of calcium ionophore (ionomycin) treat-
ment to stimulate exposure of PS on the outer surface of the plasma
membrane of normal human lymphocytes. As has been reported for
multiple cell lines, introduction of calcium into normal lymphocytes
caused immediate exposure of the anionic lipid (dotted lines in
Fig. 2A) [7]. In contrast, Raji Burkitt's lymphoma cells showed minimal
enhancement of annexin binding following ionophore treatment; 7%
of the cells stained positive for annexin V under control conditions
(similar to the other cell lines shown in Fig. 2B), and this number
increased to only 17% upon addition of ionomycin. This observation of
minimal annexin staining has been reported previously for Raji cells
under a variety of experimental conditions [29–31]. As shown in
Fig. 2B, the difference between normal (black) and Raji (dark gray)
lymphocytes was reproducible and statistically signiﬁcant. Addition of
a higher concentration of ionomycin overcame the limitation in Raji
cells, as shown by the white bar in Fig. 2B. Data obtained with S49
mouse lymphoma cells (light gray) are included as a positive reference.
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The action of sPLA2 toward normal human lymphocytes was qual-
itatively similar to that reported previously for cultured cells (Fig. 3A
and Ref. [7]). In the absence of ionomycin, a transient burst of hydro-
lysis was observed followed by slow restoration of fatty acid levels
eventually to the baseline value. This reaction proﬁle has been shown
to represent hydrolysis of a small subpopulation of cells made vulnera-
ble to the enzyme by trauma during sample preparation followed by
clearance of released fatty acid through reacylation by the other healthy
cells in the sample [5]. Addition of ionomycin enhanced the total
amount of hydrolysis observed. Both the initial rate (23%) and total
amount (87%) of hydrolysis in the normal lymphocytes (Fig. 3A) were
lower than those observed with S49 cells (Fig. 3C).
The data for control samples of Raji cells were similar to control ob-
servations for the other cell types (Fig. 3B). However, the ionophore-
treated Raji samples displayed time courses with a more complex
shape, beginning with an initial rate comparable to that of the normal
lymphocytes (Fig. 3D) followed by a latent secondary phase of hydroly-
sis that eventually matched the total of the S49 cells.
One of the challenges of comparing hydrolysis time courses beyond
the initial phase is that enzymemay eventually be able to enter the cell
and hydrolyze internal membranes thus clouding interpretation of
observed totals. It is therefore useful to also estimate the percentage
of cells for which an intact plasma membrane has been attacked by
sPLA2. As explained in earlier studies, this estimate can be obtained
using the vital stain propidium iodide [9]. Cells that resist hydrolysis
exclude the dye (low ﬂuorescence intensity) regardless of the presence
of sPLA2. Alternatively, cells that have becomevulnerable to the enzyme
ﬂuoresce brightly upon introduction of sPLA2 as hydrolysis damages the
membrane allowing propidium iodide to enter and bind to nucleic
acids. Fig. 4 displays this phenomenon for normal (Fig. 4A), Raji
(Fig. 4B), and S49 (Fig. 4C) cells. In all three cases, treatment withFig. 3. Membrane hydrolysis by sPLA2 assayed by ADIFAB ﬂuorescence. Cells were treated w
graphs). Hydrolysis of normal lymphocytes (A), Raji cells (B), and S49 cells (C) was assayed
sentation of the time proﬁle for each cell type. Dotted lines indicate the range of ± one SEM
12 s after sPLA2 addition was calculated from the data of ionomycin-treated samples in pan
these rates were statistically greater for S49 cells compared to the other cell types (pb0.00ionomycin caused all of the cells in the sample to become susceptible
to sPLA2. Moreover, the shape of the time proﬁle of propidium iodide
uptake mirrored the hydrolysis data in Fig. 3, although the proportion
of total uptake was always about one-third the proportion of total
hydrolysis at the early time points. This 3:1 ratio of percent total hydro-
lysis to percent of cells immediately permeabilized was consistent
among experimental conditions and cell types (3.2±0.5, n=19,
p=0.0003 by one-sample t-test, H0=1.0; condition not signiﬁcant by
one-way ANOVA, p=0.52).
The propidium iodide assay allowed us to use ﬂow cytometry to
determine whether the Raji cells hydrolyzed during the early phase of
the time course were those that also had phosphatidylserine exposed.
Fig. 4E shows a sample plot for cells labeledwith both propidium iodide
and annexin. As expected from the data of Panels A–D, addition of sPLA2
resulted in conversion of cells from staining negative for propidium
iodide to staining positive. Apparently, all of the cells that became
permeable to propidium iodide originated from the population that
stained positive for annexin binding (none migrated from annexin-
negative: 5.1±6.4%, n=5, p=0.47 by one-sample t-test, H0=0).
Fig. 4F shows the percentage of cells that havemigrated from the propi-
dium iodide-negative/annexin-positive ﬁeld (upper left quadrant in
Fig. 4E) to propidium iodide-positive during early hydrolysis by sPLA2
for both low and high ionomycin treatments.3.3. Changes in membrane physical properties
The data of Figs. 3 and 4 demonstrated clearly that ionophore
treatment still rendered Raji cells vulnerable to attack by sPLA2 (albeit
at a lower rate compared to S49 cells) even though little increase in
the amount of PS on the membrane surface was observed. We tested
whether other relevant membrane changes induced by ionomycin
(spacing and order of membrane lipids) were present in the Raji cells.ith ionomycin (black) or DMSO (gray) for 10 min and then with sPLA2 (time 0 on the
using ADIFAB, and the experimental data were averaged to create a composite repre-
for 3–9 independent samples. Panel D: The maximum rate of hydrolysis during the ﬁrst
els A–C. One-way analysis of variance followed by a Bonferroni post-test revealed that
1), which were indistinguishable from each other.
Fig. 4. Percentage of cells susceptible to hydrolysis by sPLA2 assayed by propidium iodide ﬂuorescence. The ﬂuorescence intensity of propidium iodide for normal lymphocytes
(A), Raji cells (B), and S49 cells (C) was measured during the ionomycin experiments of Fig. 3, and the data were averaged as explained in the legend to that ﬁgure (average:
solid, SEM: dotted). Panel D: The percentages of cells already dead (white, PIA in Fig. 1 and Eq. (2A)), killed by DMSO or Ionomycin (black, PIB in Fig. 1 and Eq. (2B)), or alive,
but susceptible to sPLA2 (gray PIC in Fig. 1 and Eq. (2C)) were calculated as explained in Materials and methods. Dotted lines and error bars represent the SEM for 3–10 independent
samples. Panel E: Contour plot from ﬂow cytometry analysis of Raji cells treated with 1.2 μM ionomycin showing numbers of cells staining negative for both annexin V binding and
propidium iodide uptake (lower left, 19%); positive for annexin V, but negative for propidium iodide (upper left, 73%); positive for both probes (upper right, 7%); and negative for
annexin V, but positive for propidium iodide (lower right, 1%). Panel F: Percentage of Raji cells originating from the upper left quadrant that stain positive for propidium iodide after
incubation with sPLA2 for the indicated times. Cells were treated with normal (600 nM, black) or high (1.2 μM, red) ionomycin prior to addition of sPLA2.
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assess these changes (Figs. 5 and 6).
Addition of ionomycin to S49 cells caused a 150% increase in the
intensity of MC540 ﬂuorescence (Fig. 5 and Ref. [7]). This intensity
change has been shown previously to represent enhanced binding
of the probe to the cell membrane [35]. This enhancement of binding
occurs when the packing of membrane lipids has become looser
resulting in greater interlipid distances [36]. The rise in MC540 emis-
sion intensity after ionomycin treatment for the normal lymphocytes
was half the size of that observed with S49 cells. For Raji cells, the
effect was even smaller, about one-ﬁfth the size of the increment in
S49 cells suggesting a link between exposure of PS and the complete
effect of ionomycin on membrane properties detected by MC540.Nevertheless, the rise in MC540 ﬂuorescence was statistically signiﬁ-
cant in each case (pb0.03 for each by one-sample t-tests with H0=0).
During hydrolysis by sPLA2, the rise in MC540 ﬂuorescence observed
in normal lymphocytes and S49 cells partially reversed (Fig. 6A and
C). In contrast, the reversal was transient in Raji cells followed by a
secondary rise that exceeded the MC540 intensity prior to addition
of sPLA2 (Fig. 6B). These observations were reproducible as shown
in Fig. 6D. Control experiments demonstrated that the drug solvent
(DMSO) had no effect on MC540 intensity (not shown).
The apparent order of membrane lipids was assessed by TMA-DPH
anisotropy; a decrease in anisotropy is generally interpreted as a re-
duction in order. As shown in Fig. 7, the initial TMA-DPH anisotropy
prior to addition of ionomycin was highly reproducible for each of
Fig. 5. Effect of ionomycin treatment on MC540 ﬂuorescence. The normalized change in
intensity of MC540 ﬂuorescence for normal lymphocytes (black), Raji cells (dark gray),
and S49 cells (light gray) was calculated as the ratio of the intensity 10 min after ionomy-
cin addition to the intensity before treatment minus 1 for 5–13 independent samples
(error bars are SEM). The effect of cell type was signiﬁcant (pb0.0001) by one-way anal-
ysis of variance. A Bonferroni post-test revealed that the S49 samples were different from
the other cell types (pb0.05), which were indistinguishable from each other.
Fig. 7. Effect of ionomycin treatment on TMA-DPH anisotropy. The baseline anisotropy
of TMA-DPH was assayed for normal lymphocytes (black), Raji cells (dark gray), and
S49 cells (light gray) (“before”, error bars are the SEM, n=5–7). The anisotropy was
then re-assessed 10 min after addition of ionomycin. The overall effects of cell type
(51.9% of the variation) and ionomycin (29.6% of the variation) were both signiﬁcant
(p≤0.0001) by two-way analysis of variance. Interaction between cell type and drug
treatment was small but signiﬁcant, indicating that the size of the effect of ionomycin
depended slightly on cell type (3.4% of the variation, p=0.0006). A Bonferroni post-
test revealed that S49 samples were different from the normal lymphocytes prior to
ionomycin (pb0.01) and that they were different from both of the other cell types
(pb0.001) after ionomycin treatment. No other pair-wise comparisons between cell
types were signiﬁcant.
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among the cells, the only difference that was statistically signiﬁcant
was between the S49 cells (light gray) and the normal lymphocytes
(black). For all three cell types, the effect of ionomycin to lower the
anisotropy was signiﬁcant. Furthermore, the decrement was greater
for S49 cells than for either of the other two. Again, the effect was
smallest with Raji cells. It has been suggested previously that iono-
phore treatment can cause cells to internalize TMA-DPH, an effect
manifest by an increase in probe emission intensity [37]. In fact,
with both S49 cells and normal lymphocytes, a reproducible rise in
TMA-DPH intensity was observed upon addition of ionomycin (S49:Fig. 6. Effect of initial membrane hydrolysis on MC540 ﬂuorescence intensity in ionomycin-
cells (B), and S49 cells (C) was measured over time following addition of ionomycin. The dat
in the ﬁgures begin approximately 600 s after that addition. Secretory PLA2 was added at th
sPLA2 was calculated for each cell type (normal lymphocytes, black; Raji, dark gray; S49, lig
variation) were signiﬁcant (p≤0.0001) by two-way analysis of variance (n=2–6). A Bonfer
time point was signiﬁcant (pb0.001), and that the 30 s point was indistinguishable betwee69.6±2.2% enhancement, pb0.0001, n=5; lymphocytes: 37.9±8.7%,
p=0.007, n=6). This result raises the question of whether the
observed change in anisotropy simply reﬂects uptake of the probe
into a more ﬂuid internal environment. Observations with the Raji
cells, clariﬁed this concern since enhanced intensity did not occur
after stimulation with ionomycin suggesting that they did not internal-
ize the probe (change in intensity=–1.1±2.6%, p=0.68, n=7). Sincetreated samples. The ﬂuorescence intensity of MC540 for normal lymphocytes (A), Raji
a were normalized to the intensity prior to addition of ionomycin, and the traces shown
e dotted lines. Panel D: The change in intensity at 30 s and again 200 s after addition of
ht gray) as explained in the legend to Fig. 5. Only the effects of cell type (90.9% of the
roni post-test revealed that every pair-wise comparison between cell types at the 200 s
n Raji and normal lymphocytes but different for S49 cells (pb0.001).
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isotropy with ionophore treatment, we concluded that at least some
of the result observed with all three cell types reﬂected disordering of
the cell membrane. This conclusion was corroborated by previously-
reported two-photon images with another probe of membrane order,
laurdan [7,8]. This interesting result also suggests that the mechanism
responsible for TMA-DPH uptake with ionophore treatment could
involve the enzyme scramblase. Control experiments demonstrated
that the drug solvent (DMSO) had no effect on TMA-DPH anisotropy
(not shown).4. Discussion
The basic question of whether exposure of PS is necessary for cells to
become vulnerable to sPLA2 was addressed by the data in this paper.
The short answer to that question appears to be “no” because only
17% of the Raji cells displayed normal exposure of PS in the presence
of ionomycin, even though 100% of the cells became susceptible to the
action of sPLA2 (Figs. 2 and 4). Nevertheless, certain nuances in the
data suggest complexities that bear further discussion on this point.
As shown in Fig. 3, the time proﬁle for hydrolysis by sPLA2 was
more complicated with Raji cells compared to normal lymphocytes
or S49 cells. In the latter two cases, the time proﬁle could be described
exactly (r2=0.999 for human lymphocytes and 1.000 for S49 cells) as
the sum of two exponential (pseudo ﬁrst-order) processes, presumably
reﬂecting diversity of substrate pools in the sample. For human lympho-
cytes, the faster component represented 59% of the hydrolysis events
with a ﬁrst-order rate constant of 0.045 s−1. The slower component
had a ﬁrst-order rate constant of 0.002 s−1. Comparable results were
identiﬁed with S49 cells, although at much higher rates (fast compo-
nent: 57% at 0.38 s−1 and slow component at 0.052 s−1). This type of
kinetic proﬁle also indicated that the process thatmade themembranes
vulnerable to hydrolysis was accomplished prior to addition of enzyme
(i.e.within 10 min incubation with ionomycin) and that only substrate
availability was limiting in the reaction thereafter. In contrast, the data
obtained from Raji cells could not be rationalized as simple ﬁrst-order
processes. Instead, the time proﬁle displayed a sharp initial hydrolysis
representing about 45% of the total lipid hydrolyzed. This initial hydro-
lysis appeared to be completed by about 70 s with a second phase that
began after a delay and displayed a modest acceleration. Such a shape
implies two populations of cells: a small percentage fully susceptible
to the enzyme (about 28%; summed from initial phase in Fig. 4B and
black+white bar segments in Fig. 4D) and a second population for
which hydrolytic capacity grows latently during the time course.
Based on the proportion of hydrolysis represented by each phase, it
appeared that the number of lipids hydrolyzed per cell was about
three times greater for the initially-vulnerable subpopulation.
Statistical comparison of the data of Figs. 2 and 4 suggested that
the subpopulation of Raji cells incorporating propidium iodide during
the ﬁrst hydrolysis phase could be synonymous with those that
exposed PS in the presence of ionomycin (p=0.40, n=4–9 by un-
paired t-test). Moreover, ﬂow cytometry analysis veriﬁed that this sub-
population of cells vulnerable to immediate attack by sPLA2 originated
entirely from cells staining positive for annexin and therefore exposing
PS. Finally, when additional PS was exposed by treatment of Raji cells
with a higher dose of ionomycin (Fig. 2B), the subpopulation attacked
by sPLA2 during the initial phase also rose (Fig. 4F). The number of
cells incorporating propidium iodide during hydrolysis observed by
ﬂow cytometry in Fig. 4F was lower than that implied by Fig. 4B due
to competition between the annexin V probe and sPLA2 [38]. Neverthe-
less, those cells that did not bind annexin V would not be subject to
competition, and none of themwere attacked by sPLA2 during the initial
hydrolysis phase. Hence,we concluded that the cells initially vulnerable
to sPLA2 and hydrolyzed at the highest rate in Raji cells were those that
displayed PS on the outer leaﬂet of the plasma membrane.A similar match between the number of Raji cells showing
exposed PS and vulnerable to sPLA2 was observed under control con-
ditions (p=0.48). Previous analysis demonstrated that hydrolysis by
sPLA2 in control samples represents elimination of a cohort of cells
already dead in culture or damaged during sample preparation [10].
Thus, the initial rates of hydrolysis in the control groups in Fig. 3
probably pertained entirely to those control cells that stained positive
for annexin V in Fig. 2 and also incorporated propidium iodide in
Fig. 4. Under such conditions, the initial hydrolysis rate in Raji cells
was indistinguishable from those observed in human lymphocytes
and S49 cells (p=0.34 by analysis of variance). When cells were stim-
ulated with ionomycin, however, nearly all the S49 cells and normal
lymphocytes, but few of the Raji cells, stained positive for PS exposure.
This event corresponded to a substantial rise in initial hydrolysis rate in
S49 cells compared to the other two cell types. Hence, the observation
that Raji cells were hydrolyzed at a rate similar to S49 cells only when
cell surface PS was expressed argues that the presence of the anionic
lipid is indeed important for efﬁcient hydrolysis of cell membranes. In
contrast, the result that hydrolysis was not stimulated in normal
lymphocytes to the same level as in S49 cells even though PS was
fully exposed in both cell types indicated that PS expression alone is
insufﬁcient.
The disproportionality between fatty acid release (ADIFAB) and the
number of cells permeablized to propidium iodide during the initial
phase of Raji cell hydrolysis was unexpected. The small cohort of cells
in control samples already dead before introduction of sPLA2 showed
the same ~3:1 disproportion of hydrolysis to permeabilization (3.93±
0.82, n=10, p=0.006 by one-sample t-test, H0=1.0). Hence, subpop-
ulations of cells must differ in the amount of hydrolysis that occurs, per-
haps reﬂecting varying degrees of accessibility of internal membranes
to the enzyme. The assumption is that those cells that are already
dead or have exposed PS in Raji samples are “super-susceptible” relative
to the others such that hydrolysis of the plasma membrane produces
sufﬁcient damage for the enzyme to interact with internal membranes.
The plasma membranes of the remaining cells in the Raji samples,
would then be hydrolyzed to a lesser extent, sufﬁcient to allow propi-
dium iodide entry but still able to exclude proteins. As evidence of this
idea, we have found frommicroscopy images after exposure of vulner-
able samples to sPLA2 that most cells remain intact, even though they
have become permeable to propidium iodide, consistent with the fact
that they remain detectable as propidium iodide-positive entities of
appropriate size by ﬂow cytometry (as in Fig. 4).
The changes in interlipid spacing and membrane order assessed in
Figs. 5 and 7 have been suggested to be essential for cells to become
susceptible to sPLA2 [7,8,39,40]. The data shown here would argue the
same since the cells hydrolyzed at the highest rate (S49) also displayed
the largest alteration in MC540 and TMA-DPH ﬂuorescence upon addi-
tion of ionomycin. In fact, a strong relationship between average
ionomycin-stimulated hydrolysis rate and the increment of change in
the emission of these probes was observed across all three cell types
(p≤0.0003 for both probes based on linear regression). Thus, it
appeared that optimal hydrolysis depended on both the presence of
PS and reduced interlipid interactions in the cell membrane. A similar
conclusion was reached previously from less direct observations of the
timing of PS exposure and vulnerability to hydrolysis during
glucocorticoid-stimulated apoptosis [10].
The second phase of hydrolysis observed in the Raji cells was unex-
pected. In a simple sense, it revealed that the cells could be completely
eliminated by sPLA2 even though initial ionomycin-stimulated PS expo-
sure was minimal. The hydrolytic acceleration associated with this
phase also demonstrated that some latent change must be occurring
in the Raji membranes that further encourages hydrolysis after those
cells with exposed PS have been exhausted. One possibility is that
anionic lipid becomes available on the cell surface as damage from
hydrolysis progresses. Assessing whether additional PS is exposed dur-
ing this latent hydrolysis phase is complicated by the fact that sPLA2 and
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Nonetheless, as shown in Fig. 4F, hydrolysis in the presence of annexin
V still proceeded, albeit at a lower rate, suggesting that any additional
exposure of PS should also be detectable even though the exact amount
would be underestimated. However, from the annexin staining
observed during the experiments of Fig. 4E and F, therewas no evidence
for increased exposure of PS during incubation with sPLA2 (increase in
annexin-positive cells after 10 min hydrolysis=–12±18%, n=4,
p=0.24; also p=0.58 by linear regression of change in annexin-
positive cells during 1–10 min hydrolysis time points, n=10).
What we can say is that the membranes of Raji cells became
increasingly perturbed during this secondary phase of hydrolysis as
assessed by MC540 ﬂuorescence. Ordinarily, as observed in both S49
cells and normal lymphocytes, the calcium-induced MC540 ﬂuores-
cence change illustrated in Fig. 5 regresses during hydrolysis by
sPLA2 probably because of membrane shrinkage as shown previously
(Fig. 6A and C, Ref. [8]). Raji cells behaved similarly during the ﬁrst
30 s after sPLA2 addition, but in contrast to the other cell types, the ﬂuo-
rescence trend thereafter reversed direction and instead increased,
reaching a plateau after 200 s (Fig. 6B). The timing of this plateau corre-
sponded to the moment of acceleration of hydrolysis illustrated in
Fig. 3B. Afterwards, the MC540 ﬂuorescence continued to rise in
synchrony with propidium iodide uptake shown in Fig. 4B while it
remained low in the other cell types (not shown). The biophysical
reasons for this effect on MC540 ﬂuorescence are unknown, but they
could relate to accumulation of reaction products in the membrane,
which is known to accelerate hydrolysis in artiﬁcial bilayers that are
not already fully susceptible [13].
In addition to addressing the potential role of PS exposure in mod-
ulating the action of sPLA2, this report provides information regarding
the relevance of studies from cultured lymphoma cells to normal
human lymphocytes. Prior to this study, all data suggesting that
nucleated cells become vulnerable to hydrolysis by sPLA2 during
biochemically-programmed death involved cultured transformed
cells. The data in this report make it clear that those studies with
cultured cell lines were relevant to normal human lymphocytes.
Nevertheless, as shown by the data of Figs. 3, 5, and 7, both the rate
of hydrolysis and the extent of relevant physical changes to the cell
membrane were substantially less in human lymphocytes compared
to S49 cells. This observation raises the question of whether there is
a difference between normal and transformed cells or whether
these parameters simply vary depending on the source of the cells
(i.e. mouse vs. human). The answer to that question requires induc-
tive logic and therefore future comparisons among many examples.
Nonetheless, preliminary ﬁndings suggest the intriguing possibility
that dying tumor cells that are not deﬁcient in their ability to expose
PS are generally more vulnerable to hydrolysis by sPLA2 than are their
normal counterparts. Data published from our lab several years ago
contained results from another human transformed lymphocyte cell
line that supported this notion (MOLT-4, acute lymphoblastic leuke-
mia) [5]. The rate of hydrolysis of this cell line during ionomycin-
induced cell death was comparable to that observed with S49 cells
(0.058 GP units · s−1, 68% of the S49 cell rate) and therefore a factor
of about three times greater than for normal lymphocytes.
There are two important implications of these ﬁndings. First,
although the presence of PS on the surface of cell membranes is an
important marker for stress responses such as blood clotting and clear-
ance of dead cells by macrophages [24,26,27,41,42], it appears to be a
secondary signal for hydrolysis of dying cells by sPLA2. As mentioned
previously, this ability of some sPLA2 isoforms to recognize dying cells
prior to or in the absence of PS exposure may be signiﬁcant for the pro-
cess of recruitment and activation of macrophages. Apparently, there
are two steps to that process, an initial “ﬁnd-me” signal for recruitment
followed by an “eat-me” signal to specify which cells will be cleared
[43,44]. While the eat-me signal almost surely represents the presence
of PS on the external face of the cell membrane, the ﬁnd-me signal maybe accomplished by the release of one of several small molecules from
the dying cell [43–47]. One of these molecules is the phospholipid
hydrolysis product lysophospholipid, which would be released by the
action of sPLA2 [44,46,47]. Since limited hydrolysis appears to be possi-
ble in the absence of PS exposure, sPLA2 would be able to help generate
theﬁnd-me signal in dying cells before it becomes capable of destroying
their membranes. Thus, the enzymemay perform a priming function to
help initiate clearance of dying cells so that macrophages are present
and ready when PS is exposed. Although sPLA2 would be now able to
hydrolyze the membrane fully and release inﬂammatory mediators in
large quantities, the cell removal by macrophages would mitigate that
effect. Recent work indicates that this hypothetical priming function
would most likely to be accomplished by the group X isoform of sPLA2
[10,17].
The second implication of this study is the possibility that death-
induced vulnerability to sPLA2, while relevant to normal human lym-
phocytes, may be quantitatively more signiﬁcant for tumor cells. This
observation, if veriﬁed, has potential therapeutic implications, both
positive and negative. On the positive side, it may suggest a novel
treatment strategy that could take advantage of the enzyme's lethal
action. However, the attack of susceptible cells by sPLA2 during
chemotherapy could produce an undesired inﬂammatory response.Acknowledgements
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